BMS and Enterome collaborate over immuno-oncology

17-11-2016

BMS and Enterome collaborate over immuno-oncology

Rawpixel.com / Shutterstock, Inc

Bristol-Myers Squibb and Enterome, a pharmaceutical development and diagnostic company, have entered into a collaboration agreement focusing on immuno-oncology.


Bristol-Myers Squibb, Enterome, immuno-oncology, collaboration

More on this story

BMS pays $1.85bn for immuno-oncology programme
15-02-2018

LSIPR